Prudential Financial Inc. reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 0.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,262,285 shares of the company’s stock after selling 11,710 shares during the period. Prudential Financial Inc. owned 0.14% of Colgate-Palmolive worth $91,957,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of the company. Jacobi Capital Management LLC lifted its holdings in Colgate-Palmolive by 125.5% in the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after buying an additional 803 shares during the period. Krilogy Financial LLC lifted its holdings in Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after buying an additional 289 shares during the period. Captrust Financial Advisors purchased a new stake in Colgate-Palmolive in the second quarter worth about $122,000. AlphaMark Advisors LLC lifted its holdings in Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after buying an additional 25 shares during the period. Finally, Bruderman Asset Management LLC purchased a new stake in Colgate-Palmolive in the second quarter worth about $126,000. Institutional investors own 72.85% of the company’s stock.
Shares of Colgate-Palmolive (CL) opened at $77.38 on Tuesday. The firm has a market cap of $68,053.16, a P/E ratio of 29.88, a P/E/G ratio of 3.24 and a beta of 0.80. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a 1 year low of $63.43 and a 1 year high of $77.91.
The company also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.07%. The ex-dividend date of this dividend is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 61.78%.
In other Colgate-Palmolive news, insider Jennifer Daniels sold 7,375 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total value of $539,702.50. Following the completion of the sale, the insider now owns 38,691 shares of the company’s stock, valued at approximately $2,831,407.38. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CMO Mukul Deoras sold 7,500 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $73.28, for a total transaction of $549,600.00. Following the completion of the sale, the chief marketing officer now directly owns 45,217 shares of the company’s stock, valued at approximately $3,313,501.76. The disclosure for this sale can be found here. Insiders have sold 181,950 shares of company stock valued at $13,237,385 in the last three months. 1.02% of the stock is owned by insiders.
Several equities analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Jefferies Group reiterated a “hold” rating and set a $79.00 target price on shares of Colgate-Palmolive in a report on Thursday, September 28th. Morgan Stanley lowered their target price on shares of Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a report on Tuesday, October 31st. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Finally, Deutsche Bank assumed coverage on shares of Colgate-Palmolive in a report on Wednesday, December 13th. They set a “hold” rating and a $75.00 target price for the company. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and six have assigned a buy rating to the company. Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $76.45.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.